Federal grants to T3D Therapeutics, Inc.
T3D Therapeutics, Inc. in Research Triangle Park, North Carolina received $16.5 million in federal grants from fiscal 2021 to 2025, across 3 awards. Its largest program was Aging Research, with $15.0 million. In fiscal 2025 it was awarded $48,055.
From USAspending.gov award records, updated November 7, 2026.
- Grants, FY 2021 to 2025$16.5 million
- Awards3
- Awarded in FY 2025$48,055
- Largest award$12.6 million
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 1 | $5.5 million |
| FY 2022 | 2 | $8.1 million |
| FY 2023 | 2 | $1.8 million |
| FY 2024 | 1 | $1.0 million |
| FY 2025 | 1 | $48,055 |
Programs that fund T3D Therapeutics, Inc.
| Program | Awards | Amount |
|---|---|---|
| Aging Research | 2 | $15.0 million |
| Extramural Research Programs in the Neurosciences and Neurological Disorders | 1 | $1.5 million |
Awarding agencies
| Agency | Awards | Amount |
|---|---|---|
| Department of Health and Human Services | 3 | $16.5 million |
Largest awards
| Award | Program | First action | Amount |
|---|---|---|---|
| Phase 2 randomized, double-blind, placebo-controlled clinical trial of T3D-959 in mild to moderate alzheimer's disease subjects | Aging Research | February 20, 2021 | $12.6 million |
| Clinical development enablement ? Long term rodent testing of the carcinogenic potential of the alzheimer?s disease drug candidate T3D-959 - T3D-959 is a new chemical entity, orally delivered, small molecule, dual nuclear receptor agonist aimed at improving dysfunctional brain glucose energy and lip | Aging Research | August 8, 2023 | $2.5 million |
| Phase 2 enabling studies of a candidate drug therapy (T3D-959) regulating neurometabolism for the treatment of huntington's disease - the recent failure of two clinical trials in huntington’s disease (HD) aimed at reducing huntingtin protein has emphasized the need to find alternative therapeutic av | Extramural Research Programs in the Neurosciences and Neurological Disorders | September 22, 2022 | $1.5 million |
Questions people ask
How much federal grant money does T3D Therapeutics, Inc. get?
$16.5 million in 3 grant awards from fiscal 2021 to 2025, as obligations reported to USAspending.gov.
Which agency gives T3D Therapeutics, Inc. the most?
The Department of Health and Human Services, with $16.5 million in 3 awards.
What is T3D Therapeutics, Inc.'s largest federal grant?
$12.6 million under Aging Research, with its first action in the period on February 20, 2021. That counts only the money obligated in fiscal 2021 to 2025.
Which federal programs fund T3D Therapeutics, Inc.?
Its largest are Aging Research and Extramural Research Programs in the Neurosciences and Neurological Disorders.
Other grant recipients in Research Triangle Park
- Research Triangle Institute
- Epicypher, Inc.
- Redbud Labs, Inc.
- Altis Biosystems, Inc.
- Dignify Therapeutics, LLC
- Zymtronix Catalytic Systems, Inc.
- 21MEDTECH LLC
- North Carolina Biotechnology Center
Largest federal grant recipients in North Carolina · Federal grants in North Carolina